Tiffany Chang

2.9k total citations · 1 hit paper
59 papers, 1.9k citations indexed

About

Tiffany Chang is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Tiffany Chang has authored 59 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 13 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Tiffany Chang's work include Hemophilia Treatment and Research (27 papers), Platelet Disorders and Treatments (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Tiffany Chang is often cited by papers focused on Hemophilia Treatment and Research (27 papers), Platelet Disorders and Treatments (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Tiffany Chang collaborates with scholars based in United States, Switzerland and Italy. Tiffany Chang's co-authors include H. Seppä, George R. Martin, Gary R. Grotendorst, Hynda K. Kleinman, Christophe Schmitt, Johannes Oldenburg, Guy Young, Gallia G. Levy, Johnny Mahlangu and Víctor Jiménez‐Yuste and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Blood.

In The Last Decade

Tiffany Chang

54 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors

2019 263 citations Guy Young, Ri Liesner et al. Blood profile →

Peers

Tiffany Chang

HEMAT

GENET

ONCOL

GENET

Thienkhai Vu United States

Vivek Patel United States

Vivian G. Oehler United States

Meral Beksaç Türkiye

Andreas Burchert Germany

Feng Lin China

Birgitta Swolin Sweden

Jan B. Egan United States

Christian Sperling Germany

Rinat Yacobi Israel

Thienkhai Vu United States

Tiffany Chang

2.6k ×2.5

HEMAT

928 ×1.9

1.2k ×3.2

GENET

172 ×0.9

ONCOL

185 ×1.2

GENET

Citations per year, relative to Tiffany Chang Tiffany Chang (= 1×) peers Thienkhai Vu

Countries citing papers authored by Tiffany Chang

Since Specialization

Citations

This map shows the geographic impact of Tiffany Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffany Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffany Chang more than expected).

Fields of papers citing papers by Tiffany Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiffany Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffany Chang. The network helps show where Tiffany Chang may publish in the future.

Co-authorship network of co-authors of Tiffany Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Tiffany Chang. A scholar is included among the top collaborators of Tiffany Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiffany Chang. Tiffany Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meyer, Ashley N. D., Tiffany Chang, Omer Liran, et al.. (2025). Schizophrenia management: Systematic review of current medications and Phase-3 agents (2008–2024). Neuroscience Applied. 4. 105507–105507. 1 indexed citations

Chang, Tiffany, et al.. (2025). The Influence of the Visual Design of Spaces on Female Speakers’ Vocal Effort: An Exploratory Study. Journal of Voice.

Chang, Tiffany, et al.. (2025). Cilia in the brain display region-dependent oscillations of length and orientation. PLoS Biology. 23(7). e3003197–e3003197.

Chen, Siwei, et al.. (2023). Reanalysis of primate brain circadian transcriptomics reveals connectivity-related oscillations. iScience. 26(10). 107810–107810. 3 indexed citations

Yang, Renchi, Shujie Wang, Xuefeng Wang, et al.. (2022). Prophylactic emicizumab for hemophilia A in the Asia‐Pacific region: A randomized study (HAVEN 5). Research and Practice in Thrombosis and Haemostasis. 6(2). e12670–e12670. 41 indexed citations

Zhao, Xiaoyi, Shady Younis, Hui Shi, et al.. (2022). RNA-seq characterization of histamine-releasing mast cells as potential therapeutic target of osteoarthritis. Clinical Immunology. 244. 109117–109117. 18 indexed citations

Chang, Tiffany, et al.. (2021). Residency Support During a Natural Disaster: Hurricane Ida. HCA Healthcare Journal of Medicine. 2(5). 315–317. 2 indexed citations

Mancuso, Maria Elisa, Johnny Mahlangu, Robert F. Sidonio, et al.. (2020). Health‐related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors—Results from the HAVEN 2 study. Haemophilia. 26(6). 1009–1018. 18 indexed citations

Callaghan, Michael U., Claude Négrier, Ido Paz‐Priel, et al.. (2020). Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies. Blood. 137(16). 2231–2242. 170 indexed citations

10.

Callaghan, Michael U., Claude Négrier, Ido Paz‐Priel, et al.. (2020). Safety and Efficacy of Emicizumab in Persons with Hemophilia a with or without FVIII Inhibitors: Pooled Data from Four Phase III Studies (HAVEN 1-4). Blood. 136(Supplement 1). 3–5. 4 indexed citations

11.

Pipe, Steven W., Rebecca Kruse‐Jarres, Johnny Mahlangu, et al.. (2020). Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database. Journal of Thrombosis and Haemostasis. 19. 21–31. 9 indexed citations

12.

Callaghan, Michael U., Benjamin Trzaskoma, Richard H. Ko, et al.. (2019). Factor VIII Use in the Treatment of Breakthrough Bleeds in Hemophilia A Patients without Inhibitors on Emicizumab Prophylaxis: The Phase 3 HAVEN 3 Study Experience. Blood. 134(Supplement_1). 2395–2395. 5 indexed citations

13.

Kruse‐Jarres, Rebecca, Michael U. Callaghan, Stacy E. Croteau, et al.. (2017). Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2). Blood. 130(Suppl_1). 89–89. 43 indexed citations

14.

Young, Guy, Robert F. Sidonio, Ri Liesner, et al.. (2017). HAVEN 2 Updated Analysis: Multicenter, Open-Label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Pediatric Patients with Hemophilia A with Inhibitors. Blood. 130(Suppl_1). 85–85. 43 indexed citations

15.

López, Enrique, Bryan Shapiro, Brigitte Vanle, et al.. (2017). Quality of life and functioning of Hispanic patients with Major Depressive Disorder before and after treatment. Journal of Affective Disorders. 225. 117–122. 6 indexed citations

16.

Akutagawa, Jon, Teng Huang, Tiffany Chang, et al.. (2016). Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras. Leukemia. 30(6). 1335–1343. 28 indexed citations

17.

Parrett, Brian M., Grant Lee, Tiffany Chang, et al.. (2016). Selective Sentinel Lymph Node Dissection in Lower Extremity Melanoma. Plastic & Reconstructive Surgery. 137(3). 1031–1038. 6 indexed citations

18.

Chang, Tiffany, Jin Xu, Jon Akutagawa, et al.. (2012). Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice. Journal of Clinical Investigation. 123(1). 335–339. 101 indexed citations

19.

Zunich, Samantha, Tiffany Chang, Wade Bushman, et al.. (2009). Paracrine sonic hedgehog signalling by prostate cancer cells induces osteoblast differentiation. Molecular Cancer. 8(1). 12–12. 40 indexed citations

20.

Chou, Yi‐Hong, et al.. (2001). Stepwise logistic regression analysis of tumor contour features for breast ultrasound diagnosis. Ultrasound in Medicine & Biology. 27(11). 1493–1498. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact